0001664115-16-000003.txt : 20160122 0001664115-16-000003.hdr.sgml : 20160122 20160121200349 ACCESSION NUMBER: 0001664115-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160122 DATE AS OF CHANGE: 20160121 EFFECTIVENESS DATE: 20160122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scythian Biosciences Inc. CENTRAL INDEX KEY: 0001664115 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-255728 FILM NUMBER: 161354561 BUSINESS ADDRESS: STREET 1: 1250-639 5TH AVENUE SW CITY: CALGARY STATE: A0 ZIP: T2P 0M9 BUSINESS PHONE: (403) 613-7310 MAIL ADDRESS: STREET 1: 1250-639 5TH AVENUE SW CITY: CALGARY STATE: A0 ZIP: T2P 0M9 D 1 primary_doc.xml X0707 D LIVE 0001664115 Scythian Biosciences Inc. 1250-639 5TH AVENUE SW CALGARY A0 ALBERTA, CANADA T2P 0M9 (403) 613-7310 CANADA (FEDERAL LEVEL) Valens Agritech Canada Inc. Spartan Cannabis Corp. None Corporation true 2014 Jonathan Gilbert 1250-639 5th Avenue SW Calgary A0 ALBERTA, CANADA T2P 0M9 Executive Officer Director Mo Fazil 1250-639 5th Avenue SW Calgary A0 ALBERTA, CANADA T2P 0M9 Executive Officer Director Harvey Lalach 1250-639 5th Avenue SW Calgary A0 ALBERTA, CANADA T2P 0M9 Executive Officer Director David Schrader 1250-639 5th Avenue SW Calgary A0 ALBERTA, CANADA T2P 0M9 Executive Officer Director Jerome Gilbert 1250-639 5th Avenue SW Calgary A0 ALBERTA, CANADA T2P 0M9 Director Michael Petter 1250-639 5th Avenue SW Calgary A0 ALBERTA, CANADA T2P 0M9 Director Allan Cohen 1250-639 5th Avenue SW Calgary A0 ALBERTA, CANADA T2P 0M9 Director Biotechnology No Revenues 06b false 2014-12-11 false true false 0 121129 121129 0 U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on December 11, 2014, which was Cdn$1.1535=US$1.00. false 7 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Scythian Biosciences Inc. /s/ Harvey Lalach Harvey Lalach Chief Financial Officer 2016-01-14